Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human cell lines.
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with ...
After hours: January 31 at 4:42:30 PM EST Loading Chart for TELO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback